BACKGROUND: Although investigations of human refractive error development and normal ocular growth have been conducted for the last 50 years, no previous study of refractive error and the ocular components has measured all the ocular components. METHODS: The Orinda Longitudinal Study of Myopia was initiated to characterize the development of refractive error and normal eye growth in a sample of predominantly Caucasian children ages 6 to 14 years. RESULTS: Cross-sectional results from 530 children ages 5 to 12 years in the 1st, 3rd, and 6th grades are presented. CONCLUSIONS: This sample's refractive error decreased toward emmetropia with age from an average of +0.73 D at age 6 years to an average of +0.50 D by age 12 years. Between the ages of 6 and 12 years, the vitreous chamber elongated (by 0.52 mm) and the crystalline lens power decreased (by 1.35 D); surprisingly, the crystalline lens thinned by 0.14 mm during this same time period.
BACKGROUND: Although investigations of human refractive error development and normal ocular growth have been conducted for the last 50 years, no previous study of refractive error and the ocular components has measured all the ocular components. METHODS: The Orinda Longitudinal Study of Myopia was initiated to characterize the development of refractive error and normal eye growth in a sample of predominantly Caucasian children ages 6 to 14 years. RESULTS: Cross-sectional results from 530 children ages 5 to 12 years in the 1st, 3rd, and 6th grades are presented. CONCLUSIONS: This sample's refractive error decreased toward emmetropia with age from an average of +0.73 D at age 6 years to an average of +0.50 D by age 12 years. Between the ages of 6 and 12 years, the vitreous chamber elongated (by 0.52 mm) and the crystalline lens power decreased (by 1.35 D); surprisingly, the crystalline lens thinned by 0.14 mm during this same time period.
Authors: Lisa A Jones-Jordan; G Lynn Mitchell; Susan A Cotter; Robert N Kleinstein; Ruth E Manny; Donald O Mutti; J Daniel Twelker; Janene R Sims; Karla Zadnik Journal: Invest Ophthalmol Vis Sci Date: 2011-03-29 Impact factor: 4.799
Authors: David Borja; Fabrice Manns; Arthur Ho; Noel Ziebarth; Alexandre M Rosen; Rakhi Jain; Adriana Amelinckx; Esdras Arrieta; Robert C Augusteyn; Jean-Marie Parel Journal: Invest Ophthalmol Vis Sci Date: 2008-03-03 Impact factor: 4.799
Authors: Jeffrey J Walline; Amber Gaume Giannoni; Loraine T Sinnott; Moriah A Chandler; Juan Huang; Donald O Mutti; Lisa A Jones-Jordan; David A Berntsen Journal: Optom Vis Sci Date: 2017-09 Impact factor: 1.973
Authors: Lisa A Jones-Jordan; Loraine T Sinnott; Susan A Cotter; Robert N Kleinstein; Ruth E Manny; Donald O Mutti; J Daniel Twelker; Karla Zadnik Journal: Invest Ophthalmol Vis Sci Date: 2012-10-01 Impact factor: 4.799
Authors: Ruth E Manny; G Lynn Mitchell; Susan A Cotter; Lisa A Jones-Jordan; Robert N Kleinstein; Donald O Mutti; J Daniel Twelker; Karla Zadnik Journal: Optom Vis Sci Date: 2011-12 Impact factor: 1.973
Authors: Donald O Mutti; Margaret E Cooper; Sarah O'Brien; Lisa A Jones; Mary L Marazita; Jeffrey C Murray; Karla Zadnik Journal: Mol Vis Date: 2007-06-28 Impact factor: 2.367